ONLINE DATABASE SEARCH - HIV-LS-293-MEMO
1. 43118 HIV-LS-293; PUBMED-HIV-4/7/2003
Preparation and antiviral properties of new acyclic, achiral nucleoside analogues: 1- or 9-[3-hydroxy-2-(hydroxymethyl)prop-1-enyl]nucleobases and 1- or 9-[2,3-dihydroxy-2-(hydroxymethyl)propyl]nucleobases
Boesen, T, Madsen, C, Sejer, Pedersen D, Nielsen, BM, Petersen, AB, Petersen, MA , Munck, M, Henriksen, U, Nielsen, C, and Dahl, O
Org Biomol Chem 2004. 2(8): 1245-1254
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15064804&dopt=abstract
2. 43119 HIV-LS-293; PUBMED-HIV-4/7/2003
Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides
Hang, JQ, Rajendran, S, Yang, Y, Li, Y, Wong, Kai In P, Overton, H, Parkes, KE, Cammack, N, Martin, JA, and Klumpp, K
Biochem Biophys Res Commun 2004. 317(2): 321-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15063760&dopt=abstract
3. 43120 HIV-LS-293; PUBMED-HIV-4/7/2003
Human immunodeficiency virus type 1 inhibitory activity of Mentha longifolia
Amzazi, S, Ghoulami, S, Bakri, Y, Il, Idrissi A, Fkih-Tetouani, S, and Benjouad, A
Therapie 2003. 58(6): 531-4
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15058498&dopt=abstract
4. 43121 HIV-LS-293; PUBMED-HIV-4/7/2003
Inhibition of HIV-1 Reverse Transcriptase and Protease by Phlorotannins from the Brown Alga Ecklonia cava
Ahn, MJ, Yoon, KD, Min, SY, Lee, JS, Kim, JH, Kim, TG, Kim, SH, Kim, NG, Huh, H, and Kim, J
Biol Pharm Bull 2004. 27(4): 544-7
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15056863&dopt=abstract
5. 43122 HIV-LS-293; PUBMED-HIV-4/7/2003
Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins
Si, Z, Madani, N, Cox, JM, Chruma, JJ, Klein, JC, Schon, A, Phan, N, Wang, L, Biorn, AC, Cocklin, S, Chaiken, I, Freire, E, Smith, AB 3rd, and Sodroski, JG
Proc Natl Acad Sci U S A 2004. 101(14): 5036-5041
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15051887&dopt=abstract
6. 43123 HIV-LS-293; PUBMED-HIV-4/7/2003
Relationship between antiviral activity and host toxicity: comparison of the incorporation efficiencies of 2',3'-dideoxy-5-fluoro-3'-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase
Feng, JY, Murakami, E, Zorca, SM, Johnson, AA, Johnson, KA, Schinazi, RF, Furman, PA, and Anderson, KS
Antimicrob Agents Chemother 2004. 48(4): 1300-6
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15047533&dopt=abstract
7. 43124 HIV-LS-293; PUBMED-HIV-4/7/2003
HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs
Perryman, AL, Lin, JH, and McCammon, JA
Protein Sci 2004. 13(4): 1108-23
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15044738&dopt=abstract
8. 43125 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients
Wood, Robin, Arasteh, Keikawus, Stellbrink, Hans-juergen, Teofilo, Eugenio, Raffi, Francois, Pollard, Richard B, Eron, Joseph, Yeo, Jane, Millard, Judith, Wire, Mary Beth, and Naderer, Odin J
Antimicrobial Agents and Chemotherapy 2004. 48(1): 116-123
9. 43126 HIV-LS-293; PUBMED-HIV-4/7/2003
Nucleosides. IX. Synthesis of purine N(3),5'-cyclonucleosides and N(3),5'-cyclo-2',3'-seconucleosides via Mitsunobu reaction as TIBO-like derivatives
Chen, GS, Chen, CS, Chien, TC, Yeh, JY, Kuo, CC, Talekar, RS, and Chern, JW
Nucleosides Nucleotides Nucleic Acids 2004. 23(1-2): 347-59
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15043159&dopt=abstract
10. 43127 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Heterocyclic compound having hiv integrase inhibitory activity((Shionogi & Co., Ltd. Japan)
Murai, Hitoshi, Endo, Takeshi, Kurose, Noriyuki, Taishi, Teruhiko, and Yoshida, Hiroshi
PATENT: WO 2004024693 A1; ISSUE DATE: 20040325
APPLICATION: 2003; PP: 396 pp.
11. 43128 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors((Merck & Co., Inc. USA)
Wai, John S, Kim, Boyoung, Fisher, Thorsten E, Zhuang, Linghang, Williams, Peter D, Lyle, Terry A, Langford, HMarie, and Robinson, Kyle A
PATENT: WO 2004024078 A2; ISSUE DATE: 20040325
APPLICATION: 2003; PP: 137 pp.
12. 43129 HIV-LS-293; PUBMED-HIV-4/7/2003
A new approach for the synthesis of novel 5-substituted isodeoxyuridine analogs
Guenther, S and Nair, V
Nucleosides Nucleotides Nucleic Acids 2004. 23(1-2): 183-93
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15043146&dopt=abstract
13. 43130 HIV-LS-293; PUBMED-HIV-4/7/2003
Nucleosides. LXV. Synthesis of new pteridine-N8-nucleosides
Matysiak, S, Waldscheck, B, and Pfleiderer, W
Nucleosides Nucleotides Nucleic Acids 2004. 23(1-2): 51-66
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15043136&dopt=abstract
14. 43131 HIV-LS-293; PUBMED-HIV-4/7/2003
Synthesis and antiviral activity of novel fluorinated 2',3'-dideoxynucleosides
Kumar, P, Ohkura, K, Balzarini, J, De Clercq, E, Seki, K, and Wiebe, LI
Nucleosides Nucleotides Nucleic Acids 2004. 23(1-2): 7-29
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15043133&dopt=abstract
15. 43132 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Understanding the integrase inhibitory activity of azido containing HIV-1 integrase inhibitors
Karki, Rajeshri G and Nicklaus, Marc C
CONFERENCE: Abstracts of Papers, 227th ACS National Meeting, Anaheim, CA, United States, March 28-April 1, 2004 2004: MEDI-017
16. 43133 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Bis-Ketol Nucleoside Triesters as Prodrugs of the Antiviral Nucleoside Triphosphate Analogues of 3'-Deoxythymidine and 3'-Deoxy-2',3'-didehydrothymidine
Calvo, Kim C, Wang, Xiaohong, and Koser, Gerald F
Nucleosides, Nucleotides & Nucleic Acids 2004. 23(3): 637-646
17. 43134 HIV-LS-293; PUBMED-HIV-4/7/2003
Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis
Witvrouw, M, Pannecouque, C, Switzer, WM, Folks, TM, De Clercq, E, and Heneine, W
Antivir Ther 2004. 9(1): 57-65
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15040537&dopt=abstract
18. 43135 HIV-LS-293; PUBMED-HIV-4/7/2003
Antiretroviral drug resistance in non-subtype B HIV-1, HIV-2 and SIV
Parkin, NT and Schapiro, JM
Antivir Ther 2004. 9(1): 3-12
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15040531&dopt=abstract
19. 43136 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Synthesis and antimicrobial activity of some novel 6-bromo-2-methyl/phenyl-3-(sulphonamido) quinazolin-4(3H)-ones
Selvam, P, Vanitha, K, Chandramohan, M, and De Clerco, E
Indian Journal of Pharmaceutical Sciences 2004. 66(1): 82-86
20. 43137 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Phosphatidylinositol 3,5-biphosphate inhibitors as antiviral agents((Piramed Limited, UK)
Parker, Peter and Waterfield, Michael
PATENT: WO 2004017950 A2; ISSUE DATE: 20040304
APPLICATION: 2003; PP: 56 pp.
21. 43138 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Use of inhibitors of acid sphingomyelinase and of acid sphingomyelinase reaction products for the prophylaxis and treatment of infectious diseases((Gulbins, Erich Germany)
PATENT: DE 10239531 A1; ISSUE DATE: 20040304
APPLICATION: 2002; PP: 10 pp.
22. 43139 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Non-peptidic protease inhibitors (NPPIs): Tipranavir
Mayers, Douglas, Curry, Kevin, Kohlbrenner, Veronika, and McCallister, Scott
Advances in Antiviral Drug Design 2004. 4: 79-98
23. 43140 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Broad spectrum substituted oxindole sulfonamide HIV protease inhibitors((Tibotec Pharmaceuticals Ltd., Ire.)
Tahri, Abdellah and Wigerinck, Piet Tom Bert Paul
PATENT: WO 2004016619 A1; ISSUE DATE: 20040226
APPLICATION: 2003; PP: 53 pp.
24. 43141 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition
Das, Atze T, Brummelkamp, Thijn R, Westerhout, Ellen M, Vink, Monique, Madiredjo, Mandy, Bernards, Rene, and Berkhout, Ben
Journal of Virology 2004. 78(5): 2601-2605
25. 43142 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Broad-spectrum 2-aminobenzothiazole sulfonamide HIV protease inhibitors((Tibotec Pharmaceuticals Ltd., Ire.)
Surleraux, Dominique Louis Nestor Ghislain, Wigerinck, Piet Tom Bert Paul, and Getman, Daniel P
PATENT: WO 2004014371 A1; ISSUE DATE: 20040219
APPLICATION: 2003; PP: 44 pp.
26. 43143 HIV-LS-293; SCIFINDER-HIV-3/30/2004
In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates
Uckun, Fatih M, Pendergrass, Sharon, Qazi, Sanjive, and Venkatachalam, Taracad K
Arzneimittel Forschung 2004. 54(1): 69-77
27. 43144 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Preparation of PEGylated T1249 polypeptide conjugates as antiviral agents((F. Hoffmann-La Roche AG, Switz.)
Bailon, Pascal Sebastian and Won, Chee-Youb
PATENT: WO 2004013165 A1; ISSUE DATE: 20040212
APPLICATION: 2003; PP: 61 pp.
28. 43145 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Antiviral pyrazines and pharmaceutical compositions containing them((Toyama Chemical Co., Ltd. Japan)
Egawa, Hiroyuki, Sugita, Atsushi, and Furuta, Yosuke
PATENT: JP 2004043371 A2; ISSUE DATE: 20040212
APPLICATION: 2002-7517; PP: 41 pp.
29. 43146 HIV-LS-293; SCIFINDER-HIV-3/30/2004
Preparation of N-(4-piperidinyl) amide compounds as chemokine receptor CCR5 modulators((AstraZeneca AB, Swed.)
Cumming, John and Winter, Jon
PATENT: WO 2004018425 A1; ISSUE DATE: 20040304
APPLICATION: 2003; PP: 43 pp.
30. 43147 HIV-LS-293; WOS-HIV-3/28/2004
Quality assurance program for clinical measurement of antiretrovirals: AIDS Clinical Trials Group proficiency testing program for pediatric and adult pharmacology laboratories
Holland, DT, DiFrancesco, R, Stone, J, Hamzeh, F, Connor, JD, and Morse, GD
ANTIMICROB AGENTS CH 2004. 48(3): 824-831
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189351700018
31. 43148 HIV-LS-293; WOS-HIV-3/28/2004
3 ' R,4 ' R-Di-(O)-(-)-camphanoyl-2 ',2 '-dimethyl-dihydropyrano [2,3-F]-chromone (DCP): A novel class of potent anti-HIV agents.
Yu, DL, Brossi, A, and Lee, KH
ABSTR PAP AM CHEM S 2003. 225: U179
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187918000961
32. 43149 HIV-LS-293; WOS-HIV-3/28/2004
Synthesis of enantiomerically pure D-FDOC and its anti-HIV activity.
Mao, SL, Liotta, DC, Bouygues, M, Welch, CJ, Biba, M, and Schinazi, RF
ABSTR PAP AM CHEM S 2003. 225: U231
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187918001244
33. 43150 HIV-LS-293; WOS-HIV-3/28/2004
Synthesis of modified nucleoside analogues as anti-HIV agents.
Reddy, VD
ABSTR PAP AM CHEM S 2003. 226: U210-U211
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187062400912
34. 43151 HIV-LS-293; WOS-HIV-3/28/2004
How a modification (8-aza-3-deaza-2 '-deoxyguanosine) influences the quadruplex structure of Hotoda's 6-mer TGGGAG with 5 '- and 3 '-end modifications
Jaksa, S, Kralj, B, Pannecouque, C, Balzarini, J, De, Clercq E, and Kobe, J
NUCLEOS NUCLEOT NUCL 2004. 23(1-2): 77-88
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220148100008
35. 43152 HIV-LS-293; WOS-HIV-3/28/2004
Second generation of cycloSal-pronucleotides with esterase-cleavable sites: The "lock-in"-concept
Meier, C, Ruppel, MFH, Vukadinovic, D, and Balzarini, J
NUCLEOS NUCLEOT NUCL 2004. 23(1-2): 89-115
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220148100009
36. 43153 HIV-LS-293; WOS-HIV-3/28/2004
Synthesis and evaluation of a novel synthetic phosphocholine lipid-AZT conjugate that double-targets wild-type and drug resistant variants of HIV
Kucera, LS, Morris-Natschke, SL, Ishaq, KS, Hes, J, Iyer, N, Furman, PA, and Fleming, RA
NUCLEOS NUCLEOT NUCL 2004. 23(1-2): 385-399
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220148100032
37. 43154 HIV-LS-293; WOS-HIV-3/28/2004
Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages
Hanley, TM, Kiefer, HLB, Schnitzler, AC, Marcello, JE, and Viglianti, GA
J VIROL 2004. 78(6): 2819-2830
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220043100017
38. 43155 HIV-LS-293; WOS-HIV-3/28/2004
New 2,4-diamino-5-(2 ',5 '-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity
Rosowsky, A, Forsch, RA, Sibley, CH, Inderlied, CB, and Queener, SF
J MED CHEM 2004. 47(6): 1475-1486
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220038700018
39. 43156 HIV-LS-293; WOS-HIV-4/4/2004
Synthesis of AZT/d4T boranophosphates as anti-HIV prodrug candidates
Lin, CX, Fu, H, Tu, GZ, and Zhao, YF
SYNTHESIS-STUTTGART 2004(4): 509-516
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220191300007
40. 43157 HIV-LS-293; WOS-HIV-4/4/2004
HIV protease inhibitor part 1: Use of Evans' oxazolidinone in intermolecular Diels-Alder reaction en route to 3,4-substituted cyclohexanones
Crackett, P, Demont, E, Eatherton, A, Frampton, CS, Gilbert, J, Kahn, I, Redshaw, S, and Watson, W
SYNLETT 2004(4): 679-683
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220191700021
41. 43158 HIV-LS-293; WOS-HIV-4/4/2004
HIV protease inhibitors part 2: [3+2] cycloaddition, isomerization; and ring expansion en route to 4,5-substituted cyclohexenones
Demont, E, Eatherton, A, Frampton, CS, Kahn, I, and Redshaw, S
SYNLETT 2004(4): 684-687
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220191700022
42. 43159 HIV-LS-293; WOS-HIV-4/4/2004
Novel peptide-based HIV-1 immunotherapy
Sommerfelt, MA, Nyhus, J, and Sorensen, B
EXPERT OPIN BIOL TH 2004. 4(3): 349-361
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220193400008
43. 43160 HIV-LS-293; WOS-HIV-4/4/2004
Novel phosphonate nucleosides as antiviral agents
Hwang, JT and Choi, JR
DRUG FUTURE 2004. 29(2): 163-177
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220229600007
44. 43161 HIV-LS-293; WOS-HIV-4/4/2004
Co-receptor antagonists as HIV-1 entry inhibitors
Shaheen, F and Collman, RG
CURR OPIN INFECT DIS 2004. 17(1): 7-16
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220248300002
45. 43162 HIV-LS-293; WOS-HIV-4/4/2004
Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of Foscarnet
Gagnard, V, Leydet, A, Morere, A, Montero, JL, Lefebvre, I, Gosselin, G, Pannecouque, C, and De, Clercq E
BIOORGAN MED CHEM 2004. 12(6): 1393-1402
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220237800014
46. 43163 HIV-LS-293; WOS-HIV-4/4/2004
HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1
Pieniazek, D, Rayfield, M, Hu, DJ, Nkengasong, JN, Soriano, V, Heneine, W, Zeh, C, Agwale, SM, Wambebe, C, Odama, L, Wiktor, SZ, and Kalish, ML
AIDS 2004. 18(3): 495-502
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000220233000016